Introduction
Within the last few years, numerous genes have been characterized that are important in regulating the cascade of events responsible for the immortalization of many dierent cell types. One of the major cell growth regulators is the tumor suppressor p53, which plays a crucial role in cell proliferation and oncogenic transformation by monitoring DNA damage and tightly regulating p53-dependent gene expression (Ko and Prives, 1996; Levine, 1997) . Mutated p53 protein, commonly found in a variety of tumors, has lost its transcriptional trans-activation activity as well as its tumor suppressor activity (Ko and Prives, 1996) . Another key regulator of the cell cycle and tumor suppression is the retinoblastoma tumor susceptibility gene product, Rb (Kaelin, 1999) . The Rb protein prevents premature G1/S transition via interaction with a variety of cellular proteins, including transcription factors such as E2F, whose functions are required to activate cell cycle regulators that are key components for G1/S phases transition (Dyson, 1998) . The widely studied ribonuclear protein, telomerase, has been shown to be important in immortalization and acts as a cellular reverse transcriptase to maintain or extend telomere length by synthesizing new telomeric DNA. The activity of telomerase is present in some germline, immortal and tumor cells, whereas it is repressed in normal human and chicken somatic cells in culture (Kim et al., 1994; Meyerson et al., 1997; Venkatesan and Price, 1998) . Recently, several studies have suggested that there may be a strong correlation between telomerase activity and cellular immortalization (Bodnar et al., 1998) . We have established in culture several immortal chicken embryo ®broblast (CEF) cell lines that are free of all known endogenous viruses (Himly et al., 1998; Schaefer-Klein et al., 1998) . All of our immortal cells expressed little or no detectable p53 mRNA with dramatically elevated E2F-1 mRNA levels. Despite numerous studies showing how p53 and E2F-1 proteins are regulated and how they exert their functional roles in cell cycle regulation, apoptosis and immortalization (Dyson, 1998; Giaccia and Kastan, 1998) , relatively little is known about the biological eects of altered p53 and E2F-1 expression at the transcriptional level in immortal cells.
Results

Altered expression of p53 and E2F-1 mRNA in immortal CEF cells
Several elegant studies have shown that the inactivation of both p53 and pRB is associated with cellular immortalization in human cells (Williams et al., 1994; Hahn et al., 1999) . We have determined the steadystate levels of p53 and E2F-1 mRNA in both primary and immortal CEF cells. Although partial nucleotide sequence analysis through critical DNA binding domains of endogenous p53 from all immortal CEF cells indicated no evident mutations (data not shown), the steady-state expression of p53 mRNA in all immortal CEF cells tested was dramatically decreased when compared to their primary cell counterparts ( Figure 1a ). In contrast, steady-state levels of E2F-1 mRNA were markedly increased in all immortal CEF cells ( Figure 1a ). It has been reported that expression levels of p53 mRNA and protein are almost equivalent in both young and old human ®broblast cells, whereas the transcriptional activity of p53 is much higher in senescent cells (Atadja et al., 1995) . Since most of our immortal CEF cell lines arose initially from later passage primary cells, we analysed the steady-state expression levels of p53 and E2F-1 mRNA in four dierent cell passages; primary presenescent (passage 4), primary senescent (passage 19), earliest immortal (immortal passage 1) and immortal (immortal passage 225). We determined whether the altered regulation of p53 and E2F-1 mRNA occurred at times speci®c to when immortal cell lines emerged from populations of senescent cells. We found that p53 mRNA was dramatically decreased in the earliest passage of immortal CEF cells that could be tested, whereas E2F-1 mRNA was considerably elevated in the same immortal CEF cells (Figure 1b) . In general, the steadystate level of any mRNA is regulated by synthesis and degradation rates. Therefore, we determined p53 and E2F-1 mRNA transcription rates in both primary and immortal CEF cells. The results indicated that the diminished steady-state expression of p53 mRNA in immortal CEF cells may not be regulated transcriptionally, since the rates of synthesis were essentially equivalent for primary and immortal CEF cells. The dierences observed in the steady-state levels of p53 mRNA may be due to an unidenti®ed post-transcriptional regulatory process (Figure 1c) . Conversely, the transcription rates of E2F-1 mRNA in immortal CEF cells increased threefold compared to primary CEF cells Figure 1d) , suggesting that the increased expression of E2F-1 mRNA was most likely due to increased transcription. The expression levels of p53 and E2F-1 proteins were con®rmed by Western blot analysis in primary and immortal CEF cells and were found to closely re¯ect the altered expression of their mRNAs (Figure 1e ). The dierential expression of both p53 and E2F-1 genes seem to be a common event in immortal CEF cells and could be an early event in the process of cellular immortalization. Furthermore, the alteration of p53 and E2F-1 expression in immortal CEF cells could have pleotrophic eects on cell growth. For instance, the expression levels of a variety of genes that play a crucial role in the regulation of cell proliferation are dramatically changed in immortal CEF cells. Such changes may be sucient to extend cellular life-span similar to the life-span extension observed by the inactivation of both p53 and Rb via introduction of SV40 large T antigen (Jha et al., 1998) .
Altered functional activity of p53 in immortal CEF cells
The ability of p53 to activate or repress transcriptionally may be an important component of its tumor suppressor function(s). It has been shown that p53 causes cell cycle arrest at the G1 and G2 checkpoints in response to DNA damage and improper mitotic events (Ko and Prives, 1996) . Although the important cell cycle regulatory genes, p21 waf1/cip1 , MDM-2, and Bax are transcriptionally induced by p53 protein, several genes associated with growth promotion or tumorigenesis including c-Fos, c-Jun, Rb, and Bcl-2 can be transcriptionally repressed by p53 (Ko and Prives, 1996 and references therein). Therefore, to assess the biological eects of reduced p53 expression in immortal CEF cells, we measured the transcription factor activity of p53 (by consensus DNA binding kinetic analysis; Figure 2a ,b) and expression levels of p53-regulated genes (by Northern blot analysis; Figure 2c ). We transfected a p53 consensus binding sequence promoter/luciferase reporter plasmid construct (p53-Luc) into primary and immortal CEF cells. The results indicated that in contrast to the activity in primary CEF cells, the overall p53 transcriptional activity in immortal CEF cells was nearly equal to that of the control reporter plasmid (Figure 2a) . Furthermore, an electrophoretic mobility shift assay showed that the p53 protein that bound to its consensus binding sequence was dramatically decreased in immortal cells compared to that of primary CEF cells (Figure 2b ). This result suggests that the reduced p53 protein levels in immortal cells could be related to the decrease in post-transcriptionally regulated p53 mRNA. The steady-state levels of MDM-2 mRNA were considerably decreased in immortal BCEFi and HCEFi cells compared to their primary cell counterparts whereas expression levels of Bcl-2, Rb, c-Fos, and c-Jun mRNA were increased in the immortal CEF cells relative to their primary cell counterparts (Figure 2c ).
Elevated functional activity of E2F-1 in immortal CEF cells
In the G1 phase of cell cycle, E2F-1 activity is suppressed by binding to hypophosphorylated Rb. However, E2F-1 can be activated in late G1 due to the dissociation from cyclin D1/CDK4/6-speci®c hyperphosphorylated Rb. In the S phase of the cell cycle, E2F-1 can be activated by cyclin E/CDK2 and cyclin A/CDK2 (Dyson, 1998; Helin, 1998) . The activated E2F-1 transcription factor has the ability to induce the expression of several genes involved in cell cycle regulation and DNA synthesis (Helin, 1998) . To determine whether the functional activity of upregulated E2F-1 mRNA in immortal cells was changed, we transfected an E2F-1 consensus binding sequence promoter/luciferase reporter plasmid construct (E2F1-Luc) into both primary and immortal CEF cells. When P-labeled chicken-speci®c p53 and E2F-1 cDNAs ampli®ed by RT ± PCR. RNA loading was monitored by reprobing membranes with chicken GAPDH. Consistent results were obtained using RNA prepared from a second independent experiment. (b) Expression levels of p53, E2F-1 and GAPDH mRNA from dierent cell passages (primary presenescent passage 4, primary senescent passage 19, earliest immortal passage 1, and immortal passage 225) were determined by semi-quantitative RT ± PCR. Identical results were obtained from three independent experiments. In (a) and (b), primary cell passage numbers are indicated in parentheses. The in vitro transcription rates were determined for p53 (c) and E2F-1 (d). Membranes were blotted with 3 mg pSK-GAPDH plasmid, 5 mg pSK plasmid and either 10 mg pSK-p53 plasmid (c) or 10 mg pSK-E2F-1 plasmid (d). GAPDH and pSK plasmids were used for positive and negative control, respectively. Transcription rates of p53 and E2F-1 mRNA were measured by hybridizing the membranes with de novo synthesized nuclear transcripts from both primary (passage 3) and immortal BCEFi (passage 145) cells. The speci®c p53 and E2F-1 transcript signals were analysed using the NIH image program. Data shown is representative of three dierent nuclear run-on experiments which were highly reproducible. (e) The expression levels of p53 and E2F-1 protein in primary and immortal CEF cells were determined by Western blot analysis. The chicken actin was immunoblotted to monitor the equal loading of cell extracts transiently transfected into immortal BCEFi and HCEFi cells, E2F1-Luc reporter activity increased 2 ± 3-fold compared to primary CEF cells (Figure 3a) . These results were further con®rmed by Northern blot analysis as shown in Figure 3b . The expression of E2F-1, cyclin A and cyclin E, known E2F-1 regulated genes, was dramatically elevated in immortal CEF cells compared to their primary cell counterparts. . DNA binding anity of endogenous chicken p53 from primary and immortal CEF cells was used to verify the levels of endogenous chicken p53 protein binding from primary and immortal CEF cells using double-stranded oligonucleotides corresponding to tetramers of the p53 binding consensus sequence. For EMSA, 50 mg of cell extract obtained from primary (breast-derived CEF passage 4 and heart-derived CEF passage 5) and immortal CEF (BCEFi passage 98 and HCEFi passage 78) cells was used. A 200-fold excess of the non-labeled double-stranded p53 consensus binding sequence was used as a sequence-speci®c competitor. Abbreviations I and P indicate the immortal and primary cells, respectively. (c) Northern blot analysis. The steady-state mRNA levels of p53-regulated genes were determined by Northern blot analysis. All of the membranes were hybridized with chicken-speci®c probes. The membranes were stained by methylene blue to monitor equal RNA loading. Consistent results were also obtained from RNA samples prepared from three independent experiments (data not shown). Primary cell passage numbers are indicated in parentheses p53 and E2F-1 expression in immortal CEF cell H Kim et al
Altered expression of cell cycle regulating genes in immortal CEF cells
The regulation of cell cycle events in a myriad of cell types has been shown to be governed, in part, by the various cyclins (Sherr, 1996) . This led us to assess the expression levels of all other currently available chicken cyclins. In immortal CEF cells, the steadystate expression levels of most of the cyclins (B2, B3, C, and D1) were up-regulated compared to primary CEF cells (Figure 4 ). Interestingly, only the expression of cyclin D2 was relatively decreased in immortal CEF cells. Although several studies have demonstrated a positive role for cyclin D2 in cell growth, recent studies have suggested that the overexpression of cyclin D2 eciently inhibited cell cycle progression and DNA synthesis (Meyyappan et al., 1998) .
Alteration of growth rates in immortal CEF cells
To further analyse the biological eects of the dierentially expressed levels of the cell cycle regulators, we examined the growth rates of primary and immortal CEF cells. As shown in Figure 5a , (Figure 5b,c) . Taken together, it seems plausible that the increased growth rates observed in immortal CEF cells may be the result of the inactivation of a negative regulator for cell growth such as p53 and/or the activation of a positive regulator such as E2F1, in addition to the activation of a variety of cyclins.
Maintenance of telomere length and chromosome integrity in immortal CEF cells
Most normal primary cells exhibit a limited life-span in culture due to replicative senescence and permanent growth arrest (Hay¯ick, 1965) . However, some normal cells can bypass replicative senescence by the exogenous introduction of viral oncoproteins such as SV40 large T antigen and HPV E6/E7 which can inactivate both p53 and Rb tumor suppressors (Shay et al., 1991) . Cells that express SV40 large T antigen can escape senescence but continue to lose telomeric repeats during their extended life span (Rubelj and Expression levels of E2F-1 and its downstream genes (cyclin A and cyclin E) were examined by Northern blot analysis. Equal loading of RNA was determined by staining membranes with methylene blue solution (data not shown). Consistent results were also obtained from semi-quantitative RT ± PCR analysis using RNA samples prepared from three independent experiments Pereira-Smith, 1994). These cells are not yet immortal, and the terminal telomeric shortening eventually causes the cells to reach a second nonproliferative stage termed`crisis' (Sedivy, 1998) . Moreover, elegant studies have shown that the onset of replicative senescence is controlled, at least in part, by the telomeric shortening that occurs each time normal human cells divide (Harley et al., 1990) . The ®rst senescence block can be overcome by viral oncogenes such as SV40 large T antigen, and the escape from the second crisis block is usually accompanied by the reactivation of telomerase (Sedivy, 1998) . Therefore, it is reasonable to question whether telomerase is reactivated and if the telomeric length is maintained in immortal CEF cells. We have determined endogenous telomerase activity using the PCR-based TRAP assay. Unexpectedly, telomerase activity was barely detectable at the various ranges of protein extracts tested (0.1 ± 10 mg) from all primary and immortal CEF cells (Figure 6a) , except for the BCEFi cell line where low telomerase activity was detected (albeit, almost 30-fold less than that from chicken primordial germ cells or from human HeLa cells; data not shown). Figure 6a is likely due to unequal DNA loading as monitored using a microsatellite probe (Figure 6c ). In addition to the maintenance of telomere length in immortal CEF cells, we con®rmed by metaphase spread analysis that BCEFi and HCEFi cells have few dicentric chromosomes (a hallmark of chromosome instability by loss of telomeric repeats), suggesting that chromosome stability is also maintained in immortal CEF cells (Figure 6d ).
Discussion
In the present study, we have examined potentially important genetic alterations in the p53 and E2F-1 expression as well as the maintenance of telomeric length that together could be crucial for the cellular immortalization of cultured CEF cells. Although numerous elegant studies have demonstrated that inactivation of p53 and Rb function by SV40 large T antigen as well as telomerase reactivation by introduction of hTERT appear to be required for immortalization of normal human cells (Hahn et al., 1999) , several lines of evidence suggest that the mechanisms for deregulating p53 and E2F-1 as well as telomeric maintenance found in the immortal CEF cells seem to be dierent from previously known genetic alterations. The functional inactivation of p53, commonly detected in a variety of immortal and tumor cells, mainly occurs through the degradation and inactivation of p53 protein. MDM-2 is largely responsible for this inactivation (Haupt et al., 1997) , in addition to several viral oncogenes such as SV40 large T antigen (Segawa et al., 1993) and HPV E6 oncoprotein (Schener et al., 1990) . A deletion of point mutation in the p53 gene also results in the loss of its crucial role in tumor suppression and cell cycle regulation. In contrast to our understanding of molecular mechanisms underlying the regulation or p53 functional activity at the translational and post-translational levels such as degradation, phosphorylation, and acetylation (Levine, 1997; Giaccia and Kastan, 1998), relatively little is known about how p53 is regulated at the transcriptional and post-transcriptional levels. In this regard, we have further con®rmed that the functional inactivation of p53 in the immortal CEF cells tested here seems to have resulted from the post-transcriptional down-regulation of its mRNA rather than transcriptional regulation (Kim et al., manuscript submitted) .
Several of the regulatory mechanisms that control E2F activity have been described (Dyson, 1998) . The transcriptional activity of E2F-1 can be either stimulated or suppressed depending on its association with Rb (i.e., regulation of E2F-1 activity is Rb dependent; Zhang et al., 1999) . The Rb activity is tightly regulated through phosphorylation and dephosphorylation by cyclin dependent kinases (cdks) and cdk inhibitors (p21 Waf/Cip and p16
INK4a
), respectively (Sherr, 1996) . The ectopic expression of p21
Waf/Cip or p16
INK4a could inactivate a variety of cyclin/cdks by which Rb is dephosphorylated and bound to E2F-1 (which would be inactive as a Rb-E2F-1 complex).
Growth of immortal DF-1 cells has been inhibited by the introduction of human p21
Waf/Cip gene (SchaeferKlein et al., 1998) and the demethylation agent, 5-azadeoxycytidine (data not shown) which was previously demonstrated to increase expression of p16 INK4a mRNA by demethylation of CpG islands in its promoter (Robertson and Jones, 1998) . Deregulation of E2F-1 activity as well as the activity of other members of the E2F family appear to be hallmarks of most human cancers where mutations in p16
INK4a
, cyclin D1, cdk4, Rb, and critical regulatory components of E2F-1 transcriptional activity have been found (Sherr, 1996) .
In immortal CEF cells, therefore, the cellular mechanism underlying functional activation of E2F-1 seems to dier with that observed from other immortal and cancer cells since deregulation of E2F-1 was a result of changes in mRNA transcription rates. Furthermore, E2F-1 mRNA was continuously upregulated in all dierent phases of the cell cycle in immortal CEF cells (and even in serum deprived culture conditions), whereas the¯uctuation in E2F-1 mRNA levels occurred in each cell division in normal cells (data not shown).
It would be interesting to elucidate the molecular mechanisms for functional deregulation of E2F-1 through increased transcription. In addition, functional studies involving the downregulation of p53 by expression of antisense p53 mRNA and upregulation of E2F-1 by introduction of exogenous E2F-1 could help determine the direct relationship between genetic alterations of p53 and E2F-1 and cellular immortalization.
In most, if not all, tumor cells, E2F-1 function has been shown to be activated not by increased mRNA and protein levels, but rather by increased protein transcriptional activity, due to the loss of Rb function. Of interest, we observed that the expression of Rb mRNA was shown to be up-regulated in immortal CEF cells. The expression of Rb mRNA is known to be repressed by p53 in mammalian cells (reviewed by Ko and Prives, 1996) . Although this has not been addressed in chicken cells, it is plausible that the observed upregulation of Rb mRNA may be the result of de-repression due to down-regulated p53. We also determined that the expression of Rb protein increased in immortal CEF cells (data not shown). This observation led us to address the phosphorylation status of Rb protein in immortal CEF cells, since the functional activity of E2F-1 as a transcriptional activator is predominately regulated by the hypo-and hyper-phosphorylation of Rb (Dyson, 1998; Helin, 1998 ). In the current study, we failed to determine Rb phosphorylation in primary and immortal CEF cells due to the lack of a speci®c anti-Rb antibody that can recognize the chicken phosphorylated Rb protein. However, it is quite likely that the increased Rb protein in immortal CEF cells may be hyper-phosphorylated (possibly due to the upregulation of most of the cyclins, e.g., A, B2, B3, C, D1 and E).
Although activation of telomerase has been shown to be an important event for cellular immortalization in normal ®broblast cells (Bodnar et al., 1998) , telomerase activity was undetectable in immortal CEF ®broblast cells in the current studies. However, telomere length was maintained in the immortal CEF cells and telomere shortening did not occur even in senescent primary CEF cells. These results indicate that maintenance of telomere length may not be directly relevant to the process of immortalization in CEF cells. However, there are questions of how telomeres and chromosome stability are maintained in the absence of detectable telomerase activity in immortal CEF cells. There are a variety of human established cell lines that do not show detectable telomerase activity. In these cells, telomeric maintenance has been proposed to occur through alternative mechanisms (Bryan et al., 1995 (Bryan et al., , 1997 . However, it is currently not known how telomeric length is maintained independently of telomerase, nor just how much telomerase activity is required for telomeric maintenance. In this regard, we propose the following possible explanations for the maintenance of telomeres in immortal CEF cells. Since the BCEFi cells showed telomerase activity at very low levels, we can not rule out the possibility that other immortal CEF cells may also have very low levels of telomerase activity (albeit undetectable by the TRAP assay used in this study). These low levels may have been sucient to maintain telomeric length and chromosome stability. Telomeric maintenance genes (i.e., positive or negative regulatory factors) may be dierentially regulated in the immortal CEF cells. Several of the genes involved in DNA recombination or repair (such as Rad 52, DNA-PK, ATM, and Rad 3) have been proposed as candidates for regulating telomeric length since mutations in these genes result in accelerated loss of telomeres (McEachern and Blackburn, 1996; Greenwell et al., 1995; Boulton and Jackson, 1996) .
In addition to the characterization of the immortalization process, it should be noted that consistent with tumorigenic conversion of immortal human cells by an oncogenic H-Ras, immortal DF-1 cells were eciently converted into transformed cells by v-Ras (Himly et al., 1998) . Furthermore, several viral and cellular oncogenes (v-Src, v-Myc, c-Myc, and c-Mos) also showed similar transforming eects in immortal DF-1 cells (Himly et al., 1998; Schaefer-Klein et al., 1998) . Therefore, the immortal CEF cells tested in the current study could serve as an excellent model to understand events leading to cellular immortalization and tumorigenesis. Figure 6 Maintenance of telomeric lengths and chromosome stability in immortal CEF cells.(a) Telomerase activity in primary (CEF18) and immortal CEF cells (DF-1, BCEFi, HCEFi) was determined by telomeric repeat ampli®cation protocol (TRAP) assay. Heat-inactivated cell extracts (HI,+) were used for negative controls, whereas the HeLa cell extract was used for a positive control. The internal control (arrow) was used to monitor the ampli®cation reaction. (b) Non-denatured genomic DNA Southern blot analysis of telomeric lengths was performed with dierent passages of both primary and immortal CEF cells. (c) The denatured genomic DNA (genomic DNA identical to that used in (b)) was hybridized with a microsatellite sequence probe to determine equal genomic DNA loading. The passage (P) and numbers across the top indicate the cell passages at which genomic DNA was prepared. The size of DNA markers appears on the left. (d) For chromosomal analysis, representative pictures were obtained by staining the metaphase chromosome spreads prepared from primary CEF, BCEFi, and HCEFi cells with propidium iodide (0.2 mg/ml)
Materials and methods
Cells and culture conditions
Primary and immortal CEF cells were seeded at 5610 5 cells/ 10 cm dish and grown in DMEM high glucose medium enriched with 10% fetal calf serum (FCS), 1% antibioticantimycotic solution, and 2 mM L-glutamine. All cell culture reagents were purchased from Gibco ± BRL. The spontaneously immortalized DF-1 CEF cell line was derived from East Lansing Line 0 (ev-0) leghorn layer embryos (Avian Disease and Oncology Laboratory, East Lansing, MI, USA). The BCEFi (Breast-derived CEF immortal), HCEFi (Heartderived CEF immortal), and SkCEFi (Skin-derived CEF immortal) cell lines were derived from speci®c pathogen free avian supply (SPAFAS) embryos (SPAFAS, Inc.). The VCEFi (Vector-derived CEF immortal) cell line was established from ev-0 embryos. Primary passage 19 cells (phenotypically senescent) were seeded at 5610 5 cells/10 cm dish and refed every 3 days for 2 weeks. Senescent cells were stained with X-gal at pH 6.0 to detect senescence-associated b-galactosidase (SA-b-gal), a histochemical marker of replicative senescence (Dimri et al., 1995) .
Northern blot and RT ± PCR analysis
Total RNA was isolated using TRIzol 1 (Gibco-BRL) from all exponentially growing immortal CEF cells and their primary cell counterparts. Total RNA (20 mg) was separated by electrophoresis on a 1% agarose gel containing formaldehyde, and blotted onto a positively charged nylon membrane (Schleicher & Schuell). The membrane was hybridized with a-32 P-dCTP labeled chicken-speci®c probes (p53, E2F1, MDM-2, Bcl-2, Rb, c-Fos, c-Jun, c-Myc and GAPDH were PCR-derived; cyclin A, B2, B3, C, D1, D2 and E cDNAs were supplied by Dr Charles J Sherr, St. Jude Children's Research Hospital). Hybridization was performed in a solution containing 50% deionized formamide, 56SSPE, 1% SDS, 106Denhardt's solution, and 200 mg/ml sonicated salmon sperm DNA at 428C for 16 h. Equal RNA loading was determined by staining the membrane with methylene blue [0.02% methylene blue and 0.3 M sodium acetate (pH 5.5)] or reprobing the membrane with either chicken GAPDH or 18S rRNA probes.
For semi-quantitative RT ± PCR, 3 mg of DNase I-treated RNA was converted to cDNA with Superscript II reverse transcriptase (Gibco ± BRL) following the manufacturer's instructions. A portion (1 ml) of the reverse transcription reaction was used to amplify p53, E2F-1, cyclin E, and GAPDH fragments (predicted size in bp) with the following speci®c Forward (F) and Reverse (R) primers: chicken p53 (F 5'-CGTTACCACGACGACGAGACCACCA-3', R 5'-TGCAGCGCCTCATTGATCTCCTT-3'; 498 bp); chicken E2F-1 (F 5'-GTCCAAGAACAACATCCAGTGGCTG-3', R 5'-GTGACAGTGCAATGAACTCATCCGC-3'; 632 bp); chicken cyclin E (F 5'-GGATCTCTGTGTGCTGGATAT-TGGC-3', R 5'-GAGTTAGAACCAGCAGAACAGGCAC-3'; 445 bp); chicken GAPDH (F 5'-TGCAGG-TGCTGAG-TATGTTGTGGA-3', R 5'-CCACAACAC-GGTTGCTGT-ATCCAA-3'; 709 bp). The p53, E2F-1 and cyclin E cDNA fragments were ampli®ed using TaKaRa Ex Taq 2 (Intergen) at 958C for 30 s, 658C for 1 min, and 728C for 45 s for 20, 22 and 20 cycles, respectively. GAPDH cDNA was ampli®ed 16 cycles to normalize the RT ± PCR reaction. Since the p53, E2F-1, cyclin E and GAPDH PCR ampli®ed products described above were non-detectable by ethidium bromide staining, all RT ± PCR products were subjected to agarose gel electrophoresis fractionation followed by transfer onto positively charged nylon membranes. The p53, E2F-1, cyclin E and GAPDH ampli®ed RT ± PCR products were veri®ed by hybridization to their respective cDNA probes, using identical conditions as described above.
Nuclear run-on assays
Approximately 10 8 cells (primary CEF passage 3 and BCEFi passage 145) were resuspended in 100 ml of a lysis buer containing 10 mM Tris-Cl (pH 7.4), 10 mM NaCl, 3 mM MgCl 2 and 0.5% (v/v) Nonidet P-40 and incubated on ice for 5 min. Nuclear pellets were recovered by centrifugation at 500 g, resuspended in 100 ml of freezing buer containing 50 mM Tris-Cl (pH 8.3), 5 mM MgCl 2 , 40% (v/v) glycerol and 0.5 mM DTT, and were frozen in liquid nitrogen. After thawing, nuclei were mixed with 100 ml of buer containing 100 mM Tris-Cl (pH 8.0), 5 mM MgCl 2 , 300 mM KCl, 0.5 mM each ATP, CTP, and GTP (Promega), and 10 ml of 32 P-UTP (800 Ci/mmol), and were incubated at 288C for 15 min. DNase I (10 mg/ml; Roche) was added at 378C for 15 min to remove genomic DNA, followed by proteinase K (200 mg/ml; Roche) treatment at 558C for 60 min. Nuclear transcripts were isolated by TRIzol 1 and puri®ed by ethanol precipitation. Hybridization conditions for nuclear run-on transcription rates were identical to those described for Northern blot analysis. Speci®c hybridization signals were analysed by the NIH image program.
Cell extracts and Western blot analysis
Total cell extract was isolated from both exponentially growing primary and immortal CEF cells using a cell lysis buer containing 20 mM HEPES (pH 7.9), 20% (v/v) glycerol, 500 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.1% (v/v) Triton X-100, 1 mM DTT and 16Protease Inhibitor Cocktail (Calbiochem). Brie¯y, cells were resuspended in cell lysis buer and gently rocked at 48C for 1 h, and then fractionated by centrifugation at 10 000 g for 15 min. Supernatants were stored at 7808C until used. The protein concentration of primary and immortal CEF cells was determined by the Bio-Rad Protein Assay following the manufacturer's instructions (BIO-RAD). Cell extracts (100 mg) were resolved on 12% SDS ± PAGE and transferred onto Immobilon-P PVDF membranes (Millipore). Immunoblotting of the membranes was performed using a 1 : 1000 dilution of anti-human p53 antibody (Ab-3, Oncogene), a 1 : 1000 dilution of anti-human E2F-1 antibody (sc-251, Santa Cruz Biotechnology, Inc.), a 1 : 1000 dilution of anti-human Rb antibody (G3-245, PharMingen), or a 1 : 1000 dilution of anti-chicken actin antibody (Ab-1, Oncogene), followed by treatment with HRP-conjugated anti-mouse IgG antibody (Amersham Pharmacia Biotech). All chicken p53, E2F-1, Rb, and actin proteins were detected by the Enhanced Chemiluminescence System (Amersham Pharmacia Biotech) following manufacturer's instructions.
Reporter plasmid constructs
The p53-Luc and E2F-1-Luc reporter plasmids were constructed in the pGL3 Luciferase reporter vector (Promega) using either double-stranded oligonucleotides corresponding to tetramers of the p53 consensus binding sequence (5'-AGGCATGCCTAGGCATGCCTAGGCATG-CCTAGGCATGCCT-3') or tetramers of the E2F-1 consensus binding sequence (5'-CGACGCGTTTTGGCGCAA-ATTTGGCGCAAATTTGGCGCAAATTTGGCGC AAACp53 and E2F-1 expression in immortal CEF cell H Kim et al TCGAGCGG-3'; 5' and 3' underlined portions of E2F-1 speci®c sequences correspond to MluI and XhoI restriction sites, respectively). The p53 consensus binding sequence (p53CBS) and E2F-1 consensus binding sequence (E2F1CBS) were cloned into the EcoRV site of pBluescript II SK (7). To construct the p53-Luc reporter plasmid, the p53CBS DNA fragment in pBluescript was digested with SacI and XhoI, gelpuri®ed, and cloned into pGL3 promoter vector. The E2F1-Luc reporter plasmid construct was prepared as above with insert orientation con®rmed by sequence analysis. The ConLuc reporter plasmid was constructed using the SacI/XhoI digested fragment (92 bp) of the multi-cloning site of pBluescript II SK (7) which was cloned into pGL3 promoter vector as above.
Transfection and reporter gene assay
Primary and immortal CEF cells were seeded at 1610 6 in 10-cm dishes 24 h prior to transfection. Transient transfection was carried out using standard calcium phosphate precipitation and glycerol shock methods. For transfection, 10 mg or 20 mg of promoter reporter plasmids (p53-Luc and E2F1-Luc) and 10 mg of control reporter plasmid (Con-Luc) were transfected together with 2 mg of pcDNA 3.1 LacZ plasmid to normalize transfection eciency. Reporter gene activity was measured 24 h after transfection. Cells were lysed with TRIzol 1 , and total RNA was isolated and treated with RNase-free DNase I to eliminate possible genomic or transfected plasmid DNA contamination. Expression levels of luciferase mRNA were determined by semi-quantitative RT ± PCR, using the identical methods as described for RT ± PCR, and quanti®ed using the NIH image program. All luciferase, GAPDH and LacZ (b-galactosidase) genes were ampli®ed with their speci®c primers at 958C (30 s), 658C (1 min), and 728C (45 s) for 16 cycles. The following speci®c Forward (F) and Reverse (R) primers were used: luciferase (F 5'-GTGTCGCTCTGCCTCATAGAACTGCCTGCG-3', R 5'-GTCTCCAGAATGTAGCCATCCATCCTTGTC-3'); LacZ (F 5'-ATCTTCCTGAGGCCGATACTGTCGT-3', R 5'-GCACATCTGAACTTCAGCCTCCAGT-3'). The relative expression levels of the luciferase reporter gene were normalized using the expression levels of GAPDH and LacZ genes.
Electrophoretic mobility shift assay
Electrophoretic mobility shift assays (EMSA) were carried out using cell extracts obtained from immortal BCEFi, HCEFi and their primary cell counterparts following procedures described previously (Chen et al., 1993) with minor modi®cations. Brie¯y, the reaction contained 16EMSA buer (20 mM HEPES pH 7.9; 25 mM KCl; 0.1 mM EDTA; 50% glycerol; 2 mM MgCl 2 ), 2 mM spermidine, 0.5 mM DTT, 0.025% NP-40, 0.1 mg/ml of BSA, 50 mg of cell extract, and 0.5 ng of 32 P-labeled probes prepared by end-labeling the double-stranded p53CBS oligonucleotide with g 32 -P-ATP. Non-labeled double-stranded p53CBS (100 ng) was used as a speci®c competitor. The reaction was carried out at room temperature for 30 min, loaded onto a native 5% polyacrylamide gel, and separated by electrophoresis in 0.56TBE at 35 mA current.
Cell growth and cell cycle analysis
To determine growth rates, primary CEF cells (passages 4 and 12) and immortal cells (BCEFi and HCEFi) were plated at a density of 1610 5 cells/10 cm dish under identical culture condition as described above. Cell numbers of both primary and immortal CEF cells were counted each day for 6 days.
Primary passage 4 and immortal CEF cells were allowed to reach about 80% con¯uence in DMEM plus 10% FCS, then half of the cultures were growth arrested by changing the medium to DMEM plus 0.1% FCS for 72 h. The DNA content of trypsinized growing and growth arrested cells was determined by staining with propidium iodide using a Cellular DNA Flow Cytometric Analysis kit (Roche). Cell cycle analysis was carried out by FACScan and analysed using a Cell Quest software program (Becton Dickinson).
Telomerase activity, telomere length and chromosome analysis Telomerase activity was analysed using the TRAPeze kit (Intergen) following the manufacturer's instructions. Telomeric lengths were determined by isolating total genomic DNA from dierent passages of primary and immortal CEF cells using the QIAGEN cell culture DNA kit (QIAGEN Inc.). The DNA was digested with HinfI and RsaI then resolved on a 0.8% agarose gel. The gel was blotted onto a positively charged nylon membrane without denaturing the DNA so that only single stranded telomeric regions could hybridize with a 32 P end-labeled (CCCTAA) 6 telomeric repeat sequence probe. To normalize the amount of DNA in each lane, a second membrane was prepared using DNA identical to that above, but denatured, so that the DNA could be hybridized to a 32 P end-labeled (AC) 12 microsatellite sequence probe.
Chromosome analysis was performed with primary (passage 3), BCEFi (passage 145) and HCEFi (passage 108) CEF cells which were allowed to grow exponentially to approximately 50% con¯uency, and then arrested for 90 min with 0.4 mg/ml of Colcemid (Gibco ± BRL). Metaphase spreads were prepared as described previously (Ponce de LeoÂ n et al., 1992) and were stained with 0.2 mg/ml of propidium iodide. Microscopic images of metaphases were acquired by a video camera on a Nikon cooled CCD microscope.
